R. Mark Adams - Jun 17, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Operating Officer
Signature
/s/ R Mark Adams by Eric L. Billings, attorney-in-fact
Stock symbol
ADPT
Transactions as of
Jun 17, 2021
Transactions value $
-$173,538
Form type
4
Date filed
6/21/2021, 08:00 PM
Previous filing
Jun 16, 2021
Next filing
Jul 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $410K +14.6K +25.1% $28.10 72.7K Jun 17, 2021 Direct F1
transaction ADPT Common Stock Sale -$583K -14.6K -20.06% $40.00* 58.1K Jun 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -14.6K -29.17% $0.00 35.4K Jun 17, 2021 Common Stock 14.6K $28.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.
F2 The options vest with respect to 1/4 of such shares on April 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.